We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.93%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36.3B
AUM Growth
-$345M
(-0.94%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-5.49%
Top 10 Holdings %
Top 10 Hldgs %
13%
Holding
771
New
91
Increased
196
Reduced
345
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CF Industries
CF
|
+$124M |
| 2 |
Merck
MRK
|
+$118M |
| 3 |
PNC Financial Services
PNC
|
+$109M |
| 4 |
STJ
St Jude Medical
STJ
|
+$108M |
| 5 |
Johnson Controls International
JCI
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$191M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$184M |
| 3 |
American Airlines Group
AAL
|
+$181M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
+$170M |
| 5 |
EMC
EMC CORPORATION
EMC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.24% |
| 2 | Technology | 11.85% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMCH
601
DELISTED
BMC Stock Holdings, Inc
BMCH
| $5.62M | 0.02% |
317,156
-13,004
| -4% | -$253K |
|
602
Itron
ITRI
$4.31B
| $5.61M | 0.02% |
+100,562
| New | +$4.82M |
|
603
Expro Ltd
XPRO
$1.73B
| $5.6M | 0.02% |
71,808
+8,334
| +13% | +$643K |
|
|
LKFT
604
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $5.5M | 0.02% |
85,000
-150,000
| -64% | -$8.45M |
|
605
Dentsply Sirona
XRAY
$2.71B
| $5.49M | 0.02% |
92,300
+26,100
| +39% | +$1.6M |
|
606
Globe Life
GL
$14.1B
| $5.39M | 0.01% |
84,342
-6,700
| -7% | -$421K |
|
607
TotalEnergies
TTE
$194B
| $5.27M | 0.01% |
+110,436
| New | +$5.28M |
|
|
NDRM
608
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $5.12M | 0.01% |
+277,000
| New | +$4.8M |
|
|
PGND
609
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
| $5.05M | 0.01% |
125,000
-185,000
| -60% | -$7.45M |
|
610
Pitney Bowes
PBI
$2.42B
| $4.86M | 0.01% |
267,496
-11,100
| -4% | -$204K |
|
611
APA Corp
APA
$12.9B
| $4.85M | 0.01% |
+75,900
| New | +$4.15M |
|
612
Ryder
R
$10B
| $4.81M | 0.01% |
73,000
-3,200
| -4% | -$209K |
|
613
Standard BioTools
LAB
$349M
| $4.81M | 0.01% |
+600,200
| New | +$5.51M |
|
|
WFM
614
DELISTED
Whole Foods Market Inc
WFM
| $4.64M | 0.01% |
163,700
-349,100
| -68% | -$10.7M |
|
|
DBD
615
DELISTED
Diebold Nixdorf Incorporated
DBD
| $4.46M | 0.01% |
+180,000
| New | +$4.78M |
|
616
Rocket Pharmaceuticals
RCKT
$346M
| $4.46M | 0.01% |
117,500
| – | – |
|
617
Southern Copper
SCCO
$144B
| $4.29M | 0.01% |
+176,165
| New | +$4.25M |
|
618
Lincoln Electric
LECO
$13.7B
| $4.27M | 0.01% |
+68,120
| New | +$4.24M |
|
|
CPHD
619
DELISTED
Cepheid Inc
CPHD
| $4.25M | 0.01% |
80,700
+5,700
| +8% | +$227K |
|
|
RXDX
620
DELISTED
Ignyta, Inc.
RXDX
| $4.25M | 0.01% |
675,000
| – | – |
|
621
Urban Outfitters
URBN
$6.47B
| $4.23M | 0.01% |
122,500
-5,300
| -4% | -$174K |
|
622
O-I Glass
OI
$1.12B
| $4.21M | 0.01% |
228,700
-259,700
| -53% | -$4.71M |
|
623
First Solar
FSLR
$22.9B
| $4.15M | 0.01% |
105,200
-4,600
| -4% | -$190K |
|
624
Marvell Technology
MRVL
$177B
| $3.98M | 0.01% |
+300,000
| New | +$3.52M |
|
|
MTVA
625
MetaVia Inc
MTVA
$7.28M
| $3.98M | 0.01% |
+6
| New | +$4.28M |
|
Similar funds
Adage Capital Partners's Q3 2016 Portfolio in Review
As of Q3 2016, Adage Capital Partners held 771 positions worth $36.3B, down 0.94% from $36.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Adage Capital Partners withdrew a net $1.99B in Q3 2016, closing 92 positions and reducing 345 holdings. Its most notable exit was MEDIVATION, INC., an estimated $170M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Kinder Morgan worth $64.8M.
- Adage Capital Partners's largest Q3 2016 buy was Kinder Morgan: 2,802,197 shares worth $64.8M.
- Adage Capital Partners added most to CF Industries in Q3 2016, an estimated $124M increase.
- Adage Capital Partners's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $191M.
- Adage Capital Partners fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $170M.
- Adage Capital Partners's ten largest holdings make up 13% of its $36.3B portfolio in Q3 2016.
- Adage Capital Partners opened 91 new positions and closed 92 in Q3 2016.
- Adage Capital Partners's portfolio value fell 0.94% quarter-over-quarter to $36.3B.
Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.